Cargando…

The elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis in breast cancer patients

BACKGROUND: The elevation of the platelet-to-lymphocyte ratio (PLR), an easily applicable blood test based on platelet and lymphocyte counts has been associated with poor prognosis in patients with different types of cancer. The present study was aimed to investigate the prognostic significance of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Krenn-Pilko, S, Langsenlehner, U, Thurner, E-M, Stojakovic, T, Pichler, M, Gerger, A, Kapp, K S, Langsenlehner, T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4021515/
https://www.ncbi.nlm.nih.gov/pubmed/24675383
http://dx.doi.org/10.1038/bjc.2014.163
_version_ 1782316250070777856
author Krenn-Pilko, S
Langsenlehner, U
Thurner, E-M
Stojakovic, T
Pichler, M
Gerger, A
Kapp, K S
Langsenlehner, T
author_facet Krenn-Pilko, S
Langsenlehner, U
Thurner, E-M
Stojakovic, T
Pichler, M
Gerger, A
Kapp, K S
Langsenlehner, T
author_sort Krenn-Pilko, S
collection PubMed
description BACKGROUND: The elevation of the platelet-to-lymphocyte ratio (PLR), an easily applicable blood test based on platelet and lymphocyte counts has been associated with poor prognosis in patients with different types of cancer. The present study was aimed to investigate the prognostic significance of the preoperative PLR in a large cohort of breast cancer patients. METHODS: Data from 793 consecutive non-metastatic breast cancer patients, treated between 1999 and 2004, were evaluated retrospectively. The optimal cutoff values for the PLR were calculated using receiver operating curve analysis. Cancer-specific survival (CSS), overall survival (OS) as well as distant metastasis-free survival (DMFS) were assessed using the Kaplan–Meier method. To evaluate the independent prognostic significance of PLR, multivariable Cox regression models were applied for all three different end points. RESULTS: Univariable analysis revealed a significant association between the elevated preoperative PLR and CSS (hazard ratio (HR): 2.75, 95% confidence interval (CI): 1.57–4.83, P<0.001) that remained statistically significant in multivariable analysis (HR: 2.03, 95% CI: 1.03–4.02, P=0.042). An increased PLR was also significantly associated with decreased OS in univariable (HR: 2.45, 95% CI: 1.43–4.20, P=0.001) and in multivariable analysis (HR: 1.92, 95% CI: 1.01–3.67, P=0.047). Furthermore, univariable analysis showed a significant impact of increased PLR on DMFS (HR: 2.02, 95% CI: 1.18–3.44, P=0.010). Subgroup analysis revealed significant associations of the elevated PLR on the primary end point CSS for all breast cancer subtypes. This association retained its significance in multivariable analysis in patients with luminal B tumours (HR: 2.538, 95% CI: 1.043–6.177, P=0.040). CONCLUSIONS: In this study, we identified the preoperative PLR as an independent prognostic marker for survival in breast cancer patients. Independent validation of our findings is needed.
format Online
Article
Text
id pubmed-4021515
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-40215152015-05-13 The elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis in breast cancer patients Krenn-Pilko, S Langsenlehner, U Thurner, E-M Stojakovic, T Pichler, M Gerger, A Kapp, K S Langsenlehner, T Br J Cancer Molecular Diagnostics BACKGROUND: The elevation of the platelet-to-lymphocyte ratio (PLR), an easily applicable blood test based on platelet and lymphocyte counts has been associated with poor prognosis in patients with different types of cancer. The present study was aimed to investigate the prognostic significance of the preoperative PLR in a large cohort of breast cancer patients. METHODS: Data from 793 consecutive non-metastatic breast cancer patients, treated between 1999 and 2004, were evaluated retrospectively. The optimal cutoff values for the PLR were calculated using receiver operating curve analysis. Cancer-specific survival (CSS), overall survival (OS) as well as distant metastasis-free survival (DMFS) were assessed using the Kaplan–Meier method. To evaluate the independent prognostic significance of PLR, multivariable Cox regression models were applied for all three different end points. RESULTS: Univariable analysis revealed a significant association between the elevated preoperative PLR and CSS (hazard ratio (HR): 2.75, 95% confidence interval (CI): 1.57–4.83, P<0.001) that remained statistically significant in multivariable analysis (HR: 2.03, 95% CI: 1.03–4.02, P=0.042). An increased PLR was also significantly associated with decreased OS in univariable (HR: 2.45, 95% CI: 1.43–4.20, P=0.001) and in multivariable analysis (HR: 1.92, 95% CI: 1.01–3.67, P=0.047). Furthermore, univariable analysis showed a significant impact of increased PLR on DMFS (HR: 2.02, 95% CI: 1.18–3.44, P=0.010). Subgroup analysis revealed significant associations of the elevated PLR on the primary end point CSS for all breast cancer subtypes. This association retained its significance in multivariable analysis in patients with luminal B tumours (HR: 2.538, 95% CI: 1.043–6.177, P=0.040). CONCLUSIONS: In this study, we identified the preoperative PLR as an independent prognostic marker for survival in breast cancer patients. Independent validation of our findings is needed. Nature Publishing Group 2014-05-13 2014-03-27 /pmc/articles/PMC4021515/ /pubmed/24675383 http://dx.doi.org/10.1038/bjc.2014.163 Text en Copyright © 2014 Cancer Research UK http://creativecommons.org/licenses/by-nc-sa/3.0/ From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
spellingShingle Molecular Diagnostics
Krenn-Pilko, S
Langsenlehner, U
Thurner, E-M
Stojakovic, T
Pichler, M
Gerger, A
Kapp, K S
Langsenlehner, T
The elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis in breast cancer patients
title The elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis in breast cancer patients
title_full The elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis in breast cancer patients
title_fullStr The elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis in breast cancer patients
title_full_unstemmed The elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis in breast cancer patients
title_short The elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis in breast cancer patients
title_sort elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis in breast cancer patients
topic Molecular Diagnostics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4021515/
https://www.ncbi.nlm.nih.gov/pubmed/24675383
http://dx.doi.org/10.1038/bjc.2014.163
work_keys_str_mv AT krennpilkos theelevatedpreoperativeplatelettolymphocyteratiopredictspoorprognosisinbreastcancerpatients
AT langsenlehneru theelevatedpreoperativeplatelettolymphocyteratiopredictspoorprognosisinbreastcancerpatients
AT thurnerem theelevatedpreoperativeplatelettolymphocyteratiopredictspoorprognosisinbreastcancerpatients
AT stojakovict theelevatedpreoperativeplatelettolymphocyteratiopredictspoorprognosisinbreastcancerpatients
AT pichlerm theelevatedpreoperativeplatelettolymphocyteratiopredictspoorprognosisinbreastcancerpatients
AT gergera theelevatedpreoperativeplatelettolymphocyteratiopredictspoorprognosisinbreastcancerpatients
AT kappks theelevatedpreoperativeplatelettolymphocyteratiopredictspoorprognosisinbreastcancerpatients
AT langsenlehnert theelevatedpreoperativeplatelettolymphocyteratiopredictspoorprognosisinbreastcancerpatients
AT krennpilkos elevatedpreoperativeplatelettolymphocyteratiopredictspoorprognosisinbreastcancerpatients
AT langsenlehneru elevatedpreoperativeplatelettolymphocyteratiopredictspoorprognosisinbreastcancerpatients
AT thurnerem elevatedpreoperativeplatelettolymphocyteratiopredictspoorprognosisinbreastcancerpatients
AT stojakovict elevatedpreoperativeplatelettolymphocyteratiopredictspoorprognosisinbreastcancerpatients
AT pichlerm elevatedpreoperativeplatelettolymphocyteratiopredictspoorprognosisinbreastcancerpatients
AT gergera elevatedpreoperativeplatelettolymphocyteratiopredictspoorprognosisinbreastcancerpatients
AT kappks elevatedpreoperativeplatelettolymphocyteratiopredictspoorprognosisinbreastcancerpatients
AT langsenlehnert elevatedpreoperativeplatelettolymphocyteratiopredictspoorprognosisinbreastcancerpatients